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Abstract
The data provided to the Genetic Analysis Workshop 14 (GAW 14) was the result of a
collaboration among several different groups, catalyzed by Elizabeth Pugh from The Center for
Inherited Disease Research (CIDR) and the organizers of GAW 14, Jean MacCluer and Laura
Almasy. The DNA, phenotypic characterization, and microsatellite genomic survey were provided
by the Collaborative Study on the Genetics of Alcoholism (COGA), a nine-site national
collaboration funded by the National Institute of Alcohol and Alcoholism (NIAAA) and the
National Institute of Drug Abuse (NIDA) with the overarching goal of identifying and characterizing
genes that affect the susceptibility to develop alcohol dependence and related phenotypes. CIDR,
Affymetrix, and Illumina provided single-nucleotide polymorphism genotyping of a large subset of
the COGA subjects. This article briefly describes the dataset that was provided.
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Complex diseases, such as alcohol dependence, are influ-
enced by genetic susceptibility, environmental factors,
and by interactions among genes and between genes and
environment. The Collaborative Study on the Genetics of
Alcoholism (COGA) has utilized a multidisciplinary
approach, bringing together expertise in many domains to
study this complex and important health problem. COGA
has been committed to sharing data with researchers in
this field to expedite progress in understanding alcohol-
ism and related phenotypes. COGA has also provided
data to Genetic Analysis Workshop 11 (GAW11) [1], and
has created an archival database of these families, with
both phenotypic data and immortalized cell lines; these




COGA was designed as a family study, incorporating
detailed assessments of the participants in many domains
to allow derivation and study of endophenotypes along
with diagnostic phenotypes. Genome surveys, using mic-
rosatellite markers, have been performed on both an ini-
tial dataset of 105 multigenerational pedigrees and a
replication dataset with 157 multigenerational pedigrees.
The results of genome surveys on these datasets have been
published [e.g., [2-6]], along with analyses that combined
the two [e.g., [7-12]]. Linkage studies of clinical pheno-
types and electrophysiological endophenotypes have led
to identification of genes involved in brain function as
well as genes involved in alcohol dependence and related
disorders. COGA has moved beyond identifying regions
of linkage and is now identifying individual genes within
those regions, using targeted single-nucleotide polymor-
phism (SNP) genotyping in which multiple SNPs were
analyzed for each regional candidate gene. Genes identi-
fied include GABRA2 [9], GABRG3 [12], and CHRM2
[10,11].
To test the relative merits of SNPs and microsatellites for
localizing genes that contribute to complex diseases and
their risk factors, COGA has collaborated with GAW and
Center for Inherited Disease Research (CIDR), who
enlisted two companies (Affymetrix and Illumina) to gen-
erate genome screens using SNPs. CIDR has provided high
throughput genotyping of short tandem repeats (STR)
markers since 1997, currently providing 11 million STR
genotypes per year. As SNP genotyping methods have
become more affordable and more amenable to genotyp-
ing large numbers of SNPs and samples, CIDR wished to
address both a perceived need in the statistical genetics
community for additional research related to the analysis
of large amounts of SNP data in pedigrees, and the need
for CIDR to test high throughput SNP platforms to make
an informed decision regarding SNP genotyping services.
To address these needs CIDR, in conjunction with Affyme-
trix and Illumina, provided SNP genotyping of the COGA
dataset for GAW14.
The Affymetrix mapping 10k assay [13-15] is an innova-
tive approach that enables rapid typing of 11,560 SNP
markers on an array using a single PCR primer and only
250 ng of genomic DNA. The Affymetrix assay uses allele
specific hybridization.
The Illumina SNP detection assay [16,17] utilizes allele-
specific extension and ligation chemistries. Total genomic
DNA is bound to paramagnetic beads. For each SNP, three
oligonucleotides are used to interrogate the locus. Two
allele-specific oligonucleotides (ASO) each incorporate
one of the two possible nucleotides. The third locus-spe-
cific oligonucleotide (LSO) anneals 1 to 20 bases down-
stream of the SNP. This LSO contains a locus-specific
address that binds to a complementary address on beads
contained in a Sentrix Array Matrix. Specific extension of
the complementary ASO occurs joining to the LSO by liga-
tion. Three universal PCR primers are used to amplify the
ligated product and incorporate allele-specific fluorescent
dyes. Up to 1,536 loci may be multiplexed in one reac-
tion. The Linkage III Panel contains over 4,600 SNP mark-
ers distributed evenly across the human genome.
Methods
COGA ascertainment and assessment
Initial ascertainment of alcohol-dependent probands
(designated Stage I) was performed by screening consecu-
tive admissions at treatment facilities. Probands were
assessed with the Semi-Structured Assessment for the
Genetics of Alcoholism (SSAGA), a comprehensive diag-
nostic instrument developed for this study and now
widely used [18,19]. Extensive histories of substance use
and abuse were gathered along with diagnostic informa-
tion for multiple Axis I disorders and antisocial personal-
ity disorder. To be recruited into the COGA study,
probands had to meet both the diagnostic criteria for alco-
hol dependence (by DSM-III-R criteria [20] and the crite-
ria for definite alcoholism specified by Feighner et al.
[21]); thus, the COGA sample is representative of a
severely alcohol-dependent population. All first degree
relatives of the probands were invited to participate. Chil-
dren and adolescents in the families were assessed with
complementary age-appropriate instruments (C-SSAGA,
child and adolescent versions). A set of control families
was ascertained to provide normative measures; they were
not screened to eliminate those with psychiatric disorders,
and are similar to a general population sample. Written
informed consent was obtained from all subjects, and the
Institutional Review Boards (IRB) of each collaborative
site approved all procedures. A more complete descriptionPage 2 of 8
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al. [1,22]. Over 13,000 individuals have been interviewed
to date.
A subset of COGA families with at least three alcohol-
dependent first degree relatives (designated Stage II) was
identified as suitable for a genetic linkage study [1]. These
families were extended by diagnostic assessment of more
distant relatives in branches reached through an affected
member. The Stage II families participated in a more com-
prehensive multi-domain assessment with an electro-
physiologic evaluation of event-related potentials (ERP),
event-related oscillations (EROs) and resting electroen-
cephalogram (EEG), endophenotypes associated with
alcohol dependence [23,24] that are more proximal to
genes and may provide measures of the liability underly-
ing a predisposition to alcohol dependence and related
disorders.
COGA whole-genome survey
A subset of the Stage II families was selected for an initial
and a replication genome survey using microsatellite
markers. These pedigrees were pruned to eliminate unin-
formative individuals and branches from the genotyped
sample. The initial sample (Wave 1) included 105 multi-
generational pedigrees that include 1,214 members, of
whom 983 individuals were genotyped. The replication
dataset (Wave 2) included 157 multigenerational pedi-
grees (1,295 individuals).
Microsatellite genotyping started well before standard
genome survey sets of markers were available, and there-
fore markers were drawn from a variety of sources [2]. Ini-
tially data were generated manually using agarose gels;
later genotyping switched to automated DNA sequencers
(ABI373, ABI377). Allele frequencies were estimated with
the USERM13 program [25] and the CRIMAP program
[26] were used to estimate marker order and distances.
Maps were generated from these data.
GAW 14 dataset
Limitations on the number of individuals who could be
genotyped for GAW14 led us to construct a family sample
of 1,353 individuals drawn from both the initial and rep-
lication datasets (Figure 1). With non-genotyped individ-
uals included for linking in the pedigrees, the 143 families
totalled 1,614 individuals. We selected the sample starting
with a core of informative families with at least 6 mem-
bers who had been interviewed and genotyped, even if
they did not have electrophysiological data. Family size
ranged from 6 to 30. Other phenotypes forwarded for
analysis included alcohol dependence, habitual smoking,
and the maximum number of drinks in a 24-hour period.
Of the 1,353 individuals selected for genotyping, 1,005
subjects had eyes closed EEG data available, while 905
subjects had Visual Oddball ERP/ERO data available.
It should be pointed out that there are differences in the
COGA clinical and electrophysiological datasets to be
analyzed by the GAW14 participants and the datasets in
the previously published COGA papers [e.g., [4-12]].
These published papers use a greater number of subjects
than that provided to the GAW14 participants. Hence,
results found by the GAW14 participants will not be iden-
tical to those previously published. The reason for the dis-
crepancy in the subject numbers provided to GAW14 is
explained in the following points:
1) Due to budgetary constraints, not all of the COGA data
were able to be genotyped for GAW14; therefore a sub-
sample of Wave 1 and Wave 2 data was selected for geno-
typing. This subsample selection was based on large
family size and interview status to obtain informative ped-
igrees. Electrophysiologic measurement was not a crite-
rion for selection. This resulted in the selection of 1,353
subjects for genotyping in GAW14. (Note that the GAW
sample consists of 1,614 individuals, because additional
non-genotyped individuals were included for linking in
the pedigrees).
2) In the COGA project, people who underwent the clini-
cal questionnaire and had blood drawn for genotyping
did not always undergo the electrophysiological battery.
Only a subset of the total Wave 1 and Wave 2 COGA data
have corresponding electrophysiological data available.
The subset of the COGA Wave 1 and Wave 2 subjects with
resting eyes closed EEG data is 1,553 (as published in
Porjesz et al. [8]). The subset of the COGA Wave 1 and
Wave 2 subjects with Visual Oddball ERP data is 1337 (as
published in Jones et al. [10]).
3) The subset of the COGA dataset selected for GAW14
genotyping and the subset of the COGA dataset with peo-
ple having electrophysiology data do not overlap com-
pletely. This means that out of the 1,353 subjects selected
COGA data subset for GAW 14Figure 1
COGA data subset for GAW 14. The GAW 14 dataset 
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EEG data available, while 905 subjects had Visual Oddball
ERP data available.
CIDR assembly of genotyping plates
For this project, 1,396 samples were received from the
COGA DNA and Cell Repository, part of the Rutgers Uni-
versity DNA and Cell Repository. The samples were
assigned arbitrary identification numbers. Five percent of
the samples were chosen to serve as internal blind dupli-
cates and given new identification numbers. Ninety-two
samples and four duplicate DNA samples were placed on
each 96-well plate.
DNA was quantified using standard PicoGreen protocols
from Molecular Probes. Two of the 96-well plates were
randomly chosen for the replication experiment at CIDR.
Identical daughter plates were robotically generated (at
concentrations appropriate for each technology, 50 ng/µl
for Affymetrix and 100 ng/µl for Illumina). Because the
performance of the Illumina assay is sensitive to low DNA
concentration, replacements for 25 samples that con-
tained less than 50 ng/µl of DNA were requested from
Rutgers and included along with the original samples sent
to Illumina. Plates were shipped to Affymetrix and Illu-
mina for genotyping in their laboratories.
Affymetrix SNP genotyping
Affymetrix was supplied with 1,396 samples (the 1,350
COGA samples along with some blind duplicates) to ana-
lyze on the GeneChip® Mapping 10k Array [27]. Total
genomic DNA was digested with the restriction enzyme
XbaI, followed by ligation of adaptors. A single primer rec-
ognizing the adaptor sequence is used to amplify the
ligated DNA fragments and PCR conditions were set to
preferentially amplify fragments in the range of 250–1000
bp. The amplified DNA was labeled and hybridized to
GeneChip® arrays containing 25-mer DNA probes
designed to hybridize with target sequence corresponding
to 11,560 SNPs which are known to be located within
fragments which will be amplified by the assay.
Each SNP is represented by 40 unique 25-mer DNA
probes scattered throughout the array: 20 probes designed
against the A allele and 20 against the B allele. Each set of
20 allele-specific probes interrogate the DNA composition
at and immediately surrounding the polymorphic site.
Relative allele signals are computed from the probe inten-
sities and are used as the input to a classification scheme
[28] that produces high-confidence genotype calls for
each SNP.
Illumina SNP genotyping
Illumina received a DNA manifest listing the plate
number, well position, and DNA concentration deter-
mined using PicoGreen for 1,396 samples. Twenty-five of
these samples were below the Illumina concentration
specifications. CIDR provided a second submission for
each of these low-concentration samples. Both the origi-
nal and replacement DNAs were genotyped and geno-
types were reported for the higher quality sample.
Illumina received a revised DNA manifest document list-
ing the plate barcode, well position, concentration, and
indicating the replacement relative to the original sample.
Illumina received 16 96-well DNA plates containing
1,421 samples that included 25 second aliquots. CIDR
placed 92 samples per plate, leaving wells A01–A04
empty for Illumina DNA control samples. Sixteen DNA
plates were accessioned into the Laboratory Information
Management System (LIMS) using uniquely barcoded
plates.
All DNA samples were quantitated in the production lab
using PicoGreen. The quantitation results were very simi-
lar to those obtained at the CIDR facility. The plates were
assigned to the GAW linkage project created in the LIMS
database, thus restricting their use to the assays in the
Linkage set.
Fan et al. [16] and Gunderson et al. [17] provide a detailed
description of the Illumina genotyping platform. All sam-
ples were genotyped using the Linkage III Panel contain-
ing 4,763 SNP markers. All genotypes were evaluated
using a quantitative quality score called GenCall score. A
GenCall score ranges from 0 to 1 and reflects the proxim-
ity within a cluster plot of the intensities of that genotype
to the centroid of the nearest cluster. In addition, we com-
pared the 25 original and replacement paired DNA sam-
ples using the GenCall score metric and selected a single
sample in each pair of first and second aliquots. Using the
GenCall score, we also identified 20 samples with very
poor genotyping quality in relation to controls and all
other samples. Poorly performing samples were removed
from the genotyping report files, and individual geno-
types with GenCall scores below 0.25 were assigned a no-
call.
Affymetrix CIDR replicate
Because CIDR hoped to determine if the Affymetrix 10k
assay could be used to quickly genotype large numbers of
samples, standard Affymetrix 10k protocols were adapted
in collaboration with Affymetrix to include automation
for all liquid handling steps in a 96-well plate format. Bar-
code tracking was used to assign plate and well positions
to specific Affymetrix GeneChips. Standard Affymetrix
protocols were used for chip handling, scanning, and data
analysis.Page 4 of 8
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The replication genotyping experiment performed by
CIDR was done using the Illumina BeadLab system. The
BeadLab system incorporates automation of all DNA and
liquid handling steps. The included LIMS incorporates
Illumina's protocols as well as tracking and enforcing
workflow. Standard Illumina protocols and reagents were
used. Data analysis was performed at CIDR using Illu-
mina's Gentrain and GTS Reports software. The cluster
definitions were defined independently on the replicate
data set.
CIDR quality control and data release
Data received from Affymetrix and Illumina were checked
for a variety of quality control measures, then combined
with COGA family file and formatted for release to
GAW14. Quality control calculations included: missing
data rates, error rates (based on lack of concordance of the
5% internal blind duplicate and the between lab replicate
genotypes), and Mendelian inconsistencies.
Results
Affymetrix SNP genotyping
Each sample in the COGA dataset was analyzed with the
standard Mapping 10k assay. Of the 1,396 samples sup-
plied, 1,381 yielded enough DNA to analyze [The follow-
ing 15 samples did not yield enough DNA to genotype:
CR1371, CR1315, CR1259, CR1169, CR0959, CR0967,
CR0859, CR0789, CR0563, CR0370, CR0269, CR0227,
CR0150, CR0047, CR0062]. The median call rate over all
1,381 samples was over 95% with an estimated accuracy
of greater than 99%. Two forms of quality control were
performed on the samples before the final submission of
the dataset to GAW14: calls on the X chromosome were
checked against the labeled sex of each sample and fami-
lies within the study were checked for Mendelian inherit-
ance errors. These quality controls revealed 10
problematic samples (sex or pedigree inconsistencies)
[The following 10 samples exhibited gender and/or Men-
delian inconsistencies: sex errors: CR1234, CR1112,
CR1125, CR1037, CR0728, CR0542; Mendelian incon-
sistencies: CR1224, CR0221; sex and Mendelian incon-
sistencies: CR1337, CR0538] in the samples supplied by
COGA.
Genetic maps were supplied with the Affymetrix Gene-
Chip® Mapping 10k Array data set to CIDR. SNPs were
mapped to unique physical positions on NCBI genome
build 34 and interpolated onto one of two framework
genetic maps: deCode [29] and Marshfield [30]. Because
those framework maps contain multiple microsatellite
markers at the same genetic location, interpolation onto
these maps can cause non-unique SNP positions. We
therefore removed all but one microsatellite marker at
each genetic location to create a non-redundant frame-
work, allowing all SNPs with unique physical positions to
also have unique interpolated genetic positions [31].
These maps are periodically updated on new versions of
the NCBI human genome sequence and are located on the
Affymetrix NetAffx website for download [32].
Illumina SNP genotyping
Production genotyping began on January 16, 2004 and
the genotyping report files were delivered on March 5,
2004, a time span of 56 days from the receipt of DNA to
data delivery. The files contained the DNA barcode ID, the
locus ID, the genotypes, and the GenCall score for each
genotype. As genotypes are designated by alleles A and B,
an allele key file was provided with context sequence for
each SNP and the designation for the nucleotides that rep-
resent alleles A and B.
Genotypes were reported for a total of 1,376 DNA sam-
ples. Of the 4,763 SNP markers, Illumina reported geno-
types for 4,752 resulting in a locus conversion rate of
99.77%. In addition, genetic map positions for each SNP
were provided from observed meiotic recombination in
28 CEPH reference pedigrees as described in Murray et al.
[33].
CIDR quality control and data release
Currently the laboratory methods used for the 10k
Affymetrix assay include multiple manual steps involving
the movement of DNA and reagents via a single-channel
or multi-channel pipettes. As a result, one sample swap
occurred in the CIDR lab. This sample problem was
detected when checking for Mendelian inconsistencies,
sex, and replicate errors. Identity by state sharing was cal-
culated within families and across all samples in the data-
set as an additional method to screen for problematic
samples. Suspect samples were re-genotyped. Confirma-
tion that the problems were resolved was achieved by
checking lab-to-lab and within-lab replicates as well as
confirming genotype concordance for 26 SNPs in com-
mon between the Affymetrix and Illumina datasets.
Two versions of the data were provided to GAW (Tables 1
and 2): raw data and clean data with Mendelian inconsist-
encies removed. Genotyping data was ordered using the
maps provided by the companies and merged with the
COGA family data to make the raw comma delimited data
files. PEDCHECK [34] was used to detect Mendelian
inconsistencies for each SNP. Level 0 and 1 checks were
run, and Mendelian inconsistencies were removed in each
nuclear family according to the rules listed below:
1) If a parent or two parents are inconsistent with a child,
the genotype of the child will be zeroed out.Page 5 of 8
(page number not for citation purposes)
BMC Genetics 2005, 6:S22) If a specific parent is inconsistent with more than 1
child, the genotype of that specific parent will be zeroed
out.
3) If two parents are inconsistent with more than 2 chil-
dren, the genotypes of the nuclear family will be zeroed
out.
After removing Mendelian inconsistencies, files in the for-
mat of MERLIN and Linkage PRE-MAKEPED were gener-
ated for each chromosome with 250 SNPs per file. SNPs
within all chromosome data files were ordered according
to the genetic map.
Conclusion
Because the families and individuals selected for genotyp-
ing as part of GAW14 were a subset of families from both
the initial and replication datasets used for COGA's pub-
lished analyses, we do not expect that results will be iden-
tical to those previously published. This Genetic Analysis
Workshop provides a remarkable opportunity to compare
genome surveys using microsatellites to those using SNPs,
in a very rich dataset that has both qualitative (e.g., diag-
nosis) and quantitative (e.g., electrophysiological) pheno-
types reflecting a common, complex disease, alcoholism.
We hope that the data we have provided will serve as a
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